SEC Form 4 · accession 0001144204-18-018810
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel E. Morse
Director
Period of report
Mar 29, 2018
Accepted (ET)
Apr 3, 2018 · 6:11 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Mar 29, 2018 | S | 4,366 | $0.805 | D | 0 | I | Joint Account with Spouse |
| Common shares, without par value | holding | — | — | — | 194,523 | D |
Table II — derivative securities
No Table II lines on this filing.